Revvity (NYSE:RVTY) Shares Sold Off by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Revvity stock on September 4th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
• Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
• Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Revvity Stock Performance

Shares of RVTY opened at $152.28 on Thursday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. Revvity Inc. has a one year low of $81.22 and a one year high of $166.25. The company has a 50-day simple moving average of $134.92 and a two-hundred day simple moving average of $112.65. The firm has a market capitalization of $16.99 billion, a PE ratio of 28.99, a price-to-earnings-growth ratio of 2.82 and a beta of 1.06.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%. The firm’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, analysts anticipate that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s payout ratio is currently 13.33%.

Wall Street Analyst Weigh In

RVTY has been the topic of a number of recent research reports. UBS Group assumed coverage on shares of Revvity in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $140.00 target price on the stock. Evercore reiterated an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Weiss Ratings raised Revvity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Finally, TD Cowen increased their target price on Revvity from $130.00 to $175.00 and gave the stock a “buy” rating in a research note on Tuesday. Five research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Revvity currently has an average rating of “Hold” and a consensus target price of $124.43.

Institutional Trading of Revvity

Institutional investors and hedge funds have recently modified their holdings of the business. Jupiter Topco LLC purchased a new stake in shares of Revvity during the second quarter valued at $961,017,000. BlackRock Inc. bought a new stake in Revvity in the 2nd quarter worth about $852,070,000. Janus Henderson Group PLC raised its position in Revvity by 7.0% in the 4th quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company’s stock worth $789,595,000 after buying an additional 533,912 shares during the last quarter. EdgePoint Investment Group Inc. raised its position in Revvity by 3.1% in the 1st quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock worth $771,044,000 after buying an additional 265,204 shares during the last quarter. Finally, State Street Corp lifted its stake in Revvity by 0.8% during the 2nd quarter. State Street Corp now owns 4,342,739 shares of the company’s stock valued at $483,173,000 after acquiring an additional 32,426 shares during the period. Institutional investors own 86.65% of the company’s stock.

Insider Transactions at Revvity

In other news, insider Tajinder Vohra sold 7,330 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the completion of the transaction, the insider directly owned 6,635 shares of the company’s stock, valued at $934,738.80. The trade was a 52.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Maxwell Krakowiak sold 1,631 shares of the firm’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $144.53, for a total transaction of $235,728.43. Following the completion of the sale, the insider owned 14,781 shares in the company, valued at $2,136,297.93. This represents a 9.94% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 9,130 shares of company stock worth $1,290,745. Insiders own 0.85% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Revvity

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.